Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
immatics biotechnologies GmbH

immatics biotechnologies GmbH (IMTXW) Stock Overview

Explore immatics biotechnologies GmbH’s financial performance, market position, analyst ratings, and future outlook.

IMTXW●NASDAQ
HealthcareBiotechnology
$0.001
$0.005(88.46%)
U.S. Market opens in 10h 43m

immatics biotechnologies GmbH (IMTXW)

Meyka AI Score

Z

Key Financials

Market Cap72.9K
P/E Ratio-4.64
EPS (TTM)$-0.19
ROE-0.45%
Fundamental Analysis

AI Price Forecasts

1 MonthN/A
3 MonthsN/A
1 Year Target$0.00

IMTXW Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of immatics biotechnologies GmbH (NASDAQ: IMTXW) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of C+, immatics biotechnologies GmbH's NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of IMTXW on the NASDAQ shows an RSI of N/A, suggesting the stock is in a an undetermined condition. Our forecasting models predict a 12-month price target of $0.00 for the NASDAQ listing.

Key metrics behind immatics biotechnologies GmbH's NASDAQ-traded stock include a P/E ratio of -4.64 and a market capitalization of 72.9K. Combined with our AI analysis, these give both institutional and retail investors a clear view of IMTXW on the NASDAQ.

Price Performance (NASDAQ: IMTXW)

1-Day Change
N/A
5-Day Change
N/A
1-Month Change
-0.00%
3-Month Change
-97.00%
6-Month Change
-98.78%
Year-to-Date (YTD) Change
-99.80%
1-Year Change
-99.98%
3-Year Change
-99.98%
5-Year Change
-99.98%
All-Time (Max) Change
-99.99%

Contact Information

https://www.immatics.com
49 7071 5397 0
Paul-Ehrlich-Strasse 15, Tübingen, NaN, 72076

Company Facts

5,540 Employees
IPO DateJul 2, 2020
CountryUS

Frequently Asked Questions